Whereas, this study indicates that a normalized BCR signal could restore immune tolerance, the strong role of CD40 activation in PTPN22 risk gene carriers is also consistent with the idea that this pathway is critical for censoring the overly active immune system in autoimmunity (95). This evidence concerns the gene BCR and Autoimmunity.